CANTARUTTI ANNA

Di Chiara, C., Cantarutti, A., Raffaella Petrara, M., Bonfante, F., Benetti, E., Boracchini, R., et al. (2024). Stronger and durable SARS-CoV-2 immune response to mRNA vaccines in 5-11 years old children with prior COVID-19. VACCINE, 42(2), 263-270 [10.1016/j.vaccine.2023.12.006]. Dettaglio

Di Chiara, C., Boracchini, R., Cantarutti, A., Kakkar, F., Oletto, A., Padoan, A., et al. (2024). Risk of SARS-CoV-2 Reinfection in Children Within the 12 Months Following Mild COVID-19: Insights From a Survey Study. THE PEDIATRIC INFECTIOUS DISEASE JOURNAL, 43(4), 128-130 [10.1097/INF.0000000000004233]. Dettaglio

Brigadoi, G., Demarin, G., Boracchini, R., Pierantoni, L., Rossin, S., Barbieri, E., et al. (2024). Comparison between the Viral Illness Caused by SARS-CoV-2, Influenza Virus, Respiratory Syncytial Virus and Other Respiratory Viruses in Pediatrics. VIRUSES, 16(2) [10.3390/v16020199]. Dettaglio

Dichiara, C., Barbieri, E., Chen, Y., Visona, E., Cavagnis, S., Sturniolo, G., et al. (2023). Comparative study showed that children faced a 78% higher risk of new-onset conditions after they had COVID-19. ACTA PAEDIATRICA, 112(12 (December 2023)), 2563-2571 [10.1111/apa.16966]. Dettaglio

Barbieri, E., Cavagnis, S., Scamarcia, A., Cantarutti, L., Bertizzolo, L., Bangert, M., et al. (2023). Assessing the burden of bronchiolitis and lower respiratory tract infections in children ≤24 months of age in Italy, 2012–2019. FRONTIERS IN PEDIATRICS, 11 [10.3389/fped.2023.1143735]. Dettaglio